Effects of Clostridium tyrobutyricum on Lipid Metabolism, Intestinal Barrier Function, and Gut Microbiota in Obese Mice Induced by High-Fat Diet
Open Access
Abstract
Obesity and its complications constitute a main threat to global human health. The purpose of this investigation was to explore the influences of Clostridium tyrobutyricum (Ct) on lipid metabolism, intestinal barrier function, and intestinal microbiome in obese mice induced by a high-fat diet (HFD). After establishing the obesity model, 107 CFU/mL and 108 CFU/mL C. tyrobutyricum were used to intervene in HFD-fed mice by gavage for six weeks, and indexes related to obesity were measured. In the liver of HFD-fed mice, the results revealed that C. tyrobutyricum reduced liver weight and the levels of triglyceride (TG), total cholesterol (TC), and nonesterified fatty acid (NEFA), along with decreasing red lipid droplets and fat vacuoles. After C. tyrobutyricum intervention, the mRNA expression of peroxisome proliferator-activated receptor-γ (PPARγ) was downregulated, and AMP-activated protein kinase (AMPK), peroxisome proliferator-activated receptor-α (PPARα), adipose triglyceride lipase (ATGL), and hormone-sensitive lipase (HSL) were upregulated in the liver. Additionally, C. tyrobutyricum alleviated intestinal morphology injury caused by HFD, decreased the expression of tumor necrosis factor-α (TNF-α), interleukin 6 (IL-6), and IL-1β in the colon, and upregulated tight junction protein expression. In addition, 16S rRNA sequencing revealed that C. tyrobutyricum increases the diversity of intestinal microbiota. Overall, C. tyrobutyricum improved HFD-induced lipid metabolism disorders, preserved the intestinal barrier’s integrity, and modulated the structure of the intestinal microbiome. These findings provide a novel insight into the role of C. tyrobutyricum as a probiotic in regulating lipid metabolism.Keywords
Funding Information
- Anji County Bamboo Industry Scientific and Technological Innovation Research and Development Project (202212, 2018YFE0112700)
- National Key Research and Development Program of China (202212, 2018YFE0112700)
This publication has 69 references indexed in Scilit:
- Dietary nano-selenium alleviated intestinal damage of juvenile grass carp (Ctenopharyngodon idella) induced by high-fat diet: Insight from intestinal morphology, tight junction, inflammation, anti-oxidization and intestinal microbiotaAnimal Nutrition, 2021
- Role of gut microbiota in type 2 diabetes pathophysiologyEBioMedicine, 2020
- Sodium Butyrate Ameliorates Intestinal Injury and Improves Survival in a Rat Model of Cecal Ligation and Puncture-Induced SepsisInflammation, 2019
- Non-alcoholic fatty liver disease – A global public health perspectiveJournal of Hepatology, 2019
- Sodium Butyrate Inhibits Inflammation and Maintains Epithelium Barrier Integrity in a TNBS-induced Inflammatory Bowel Disease Mice ModelEBioMedicine, 2018
- GC-MS Analysis of Short-Chain Fatty Acids in Feces, Cecum Content, and Blood Samples2018
- Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseasesJournal of Gastroenterology, 2016
- Gut–liver axis, nutrition, and non-alcoholic fatty liver diseaseClinical Biochemistry, 2015
- Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioningHepatology, 2010
- Diet-Induced Obesity Is Linked to Marked but Reversible Alterations in the Mouse Distal Gut MicrobiomeCell Host & Microbe, 2008